S-1 for treatment of advanced hepatocellular carcinoma: a systematic review of the literature

Hepatocellular carcinoma (HCC) is the most common liver neoplasm worldwide. Based on its potent inhibition of dihydropyrimidine dehydrogenase (DPD), S-1 is expected to be more active than other fluoropyrimidines against HCC with DPD activity. This systematic review was aimed to assess the efficacy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wu-kui, You, Li-na, Yang, Shu-fa, Liu, Deng-yao, Liu, Mo, Fan, Xi-wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Review Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385475/
https://www.ncbi.nlm.nih.gov/pubmed/28435393
http://dx.doi.org/10.5114/wo.2017.66653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385475/
https://www.ncbi.nlm.nih.gov/pubmed/28435393
http://dx.doi.org/10.5114/wo.2017.66653

Ejemplares similares